Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Bortezomib Refractory Multiple Myeloma”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01177683
What this trial is testing

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sherif Farag, MB, BS 32
Testing effectiveness (Phase 2)WithdrawnNCT01332617
What this trial is testing

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Who this might be right for
Myeloma
University of Louisville
Not applicableStudy completedNCT00569868
What this trial is testing

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
MULTIPLE MYELOMA
University of Arkansas 11
Testing effectiveness (Phase 2)Ended earlyNCT01484626
What this trial is testing

Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Loyola University 3
Early research (Phase 1)Ended earlyNCT00560352
What this trial is testing

Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Study completedNCT00095680
What this trial is testing

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Scios, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02654990
What this trial is testing

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
pharmaand GmbH 248
Early research (Phase 1)Study completedNCT01497093
What this trial is testing

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 34
Testing effectiveness (Phase 2)Study completedNCT00378209
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 65
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Testing effectiveness (Phase 2)UnknownNCT01522872
What this trial is testing

Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Threshold Pharmaceuticals 98
Large-scale testing (Phase 3)Study completedNCT01324947
What this trial is testing

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 74
Large-scale testing (Phase 3)Study completedNCT02136134
What this trial is testing

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 498
Testing effectiveness (Phase 2)Ended earlyNCT01695330
What this trial is testing

Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens

Who this might be right for
Multiple Myeloma
Oncotherapeutics 5
Testing effectiveness (Phase 2)Study completedNCT02290431
What this trial is testing

Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapse/Refractory Multiple Myeloma
Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT00216697
What this trial is testing

An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 13
Testing effectiveness (Phase 2)Study completedNCT02467010
What this trial is testing

Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance

Who this might be right for
Multiple Myeloma
University Medical Center Groningen 73
Large-scale testing (Phase 3)Active Not RecruitingNCT06868667
What this trial is testing

Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02773030
What this trial is testing

Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 466
Testing effectiveness (Phase 2)Study completedNCT03242460
What this trial is testing

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed and/or refractorY Multiple Myeloma
Kosin University Gospel Hospital 55
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation